Oak Pharma SRL
Oak Pharma reported total assets of 468,141 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Oak Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oak Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 48,250 € | ||||
| Equity | 78,004 € | ||||
| Cash | 12,897 € | ||||
| EBITDA | 172,152 € | ||||
| Total assets | 468,141 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Oak Pharma's financial analysis
- Solvency16.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oak Pharma
Oak Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0655.792.749
- VAT number
- BE0655792749
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 30 May 2016
- Registered office
- 8020 Oostkamp
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Oak Pharma (SRL) has been based in Oostkamp since 2016, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 48,250 € and equity of 78,004 €; its revenue is not published. Its solvency stands at 16.7%, below the median of its sector (46.0%).
Companies similar to Oak Pharma
Companies in the same business, of comparable size and area, outside its group.
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- RNA Pioneering Business and other management consultancy activities Ghent · balance sheet €5.63m
- Keypharm Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet €9.49m
- Meda Bright Wholesale of pharmaceutical and medical goods Brussels · balance sheet 469,972 €
- Medys Wholesale of pharmaceutical and medical goods Kapellen · balance sheet 774,225 €
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- MFI Wholesale of pharmaceutical and medical goods Ouffet · balance sheet €1.03m
Frequently asked questions about Oak Pharma
What is the revenue of Oak Pharma?
Oak Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oak Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0655792749 for Oak Pharma, if the company is VAT-registered. Its company number (CBE) is 0655.792.749.
Where is the registered office of Oak Pharma?
According to the CBE register, the registered office of Oak Pharma is in 8020 Oostkamp.
What is the equity of Oak Pharma?
At the close of the 2025 financial year, the equity of Oak Pharma amounts to 78,004 €, a solvency of 16.7% of total assets.
Who manages Oak Pharma?
The register lists 8 active mandates at Oak Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oak Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →